<?xml version="1.0" encoding="utf-8"?><rss version="2.0">
<channel>
<title>IM Vaccine</title>
<link>http://www.imvaccine.com/</link>
<description>IM Vaccine News Feed</description>
<category>vaccine, cancer, medical</category>
<generator></generator>
<webMaster>techsupport@impactcommuncations.ca</webMaster>
		<item>
		<title>Immunovaccine Signs Collaboration to Develop Sustained-Acting, Single Dose Vaccines for Pets</title>
		<link>http://www.imvaccine.com/releases.php?releases_id=274</link>
		<date>Fri, 18 May 2012 00:00:00 PDT</date>
		<description>Immunovaccine Signs Collaboration to Develop Sustained-Acting, Single Dose Vaccines for Pets</description>
		<author></author>
		<category></category>
		</item>
		 		<item>
		<title>Biotech Investment Banker Léouzon to Join Immunovaccine Board</title>
		<link>http://www.imvaccine.com/releases.php?releases_id=273</link>
		<date>Fri, 18 May 2012 00:00:00 PDT</date>
		<description>Biotech Investment Banker Léouzon to Join Immunovaccine Board</description>
		<author></author>
		<category></category>
		</item>
		 		<item>
		<title>Immunovaccine Announces 2011 Year-End Results</title>
		<link>http://www.imvaccine.com/releases.php?releases_id=272</link>
		<date>Fri, 18 May 2012 00:00:00 PDT</date>
		<description>Immunovaccine Announces 2011 Year-End Results</description>
		<author></author>
		<category></category>
		</item>
		 		<item>
		<title>Immunovaccine Inc. Named “Best Early-Stage Vaccine Biotech” at the 5th Vaccine Industry Excellence (ViE) Awards</title>
		<link>http://www.imvaccine.com/releases.php?releases_id=271</link>
		<date>Fri, 18 May 2012 00:00:00 PDT</date>
		<description>Immunovaccine Inc. Named “Best Early-Stage Vaccine Biotech” at the 5th Vaccine Industry Excellence (ViE) Awards</description>
		<author></author>
		<category></category>
		</item>
		 		<item>
		<title>Immunovaccine Presents Findings of Cancer Vaccine Studies at AACR Meeting</title>
		<link>http://www.imvaccine.com/releases.php?releases_id=270</link>
		<date>Fri, 18 May 2012 00:00:00 PDT</date>
		<description>Immunovaccine Presents Findings of Cancer Vaccine Studies at AACR Meeting</description>
		<author></author>
		<category></category>
		</item>
		 		<item>
		<title>Immunovaccine Modifies the Terms of the Finders’ Fees Previously Announced</title>
		<link>http://www.imvaccine.com/releases.php?releases_id=269</link>
		<date>Fri, 18 May 2012 00:00:00 PDT</date>
		<description>Immunovaccine Modifies the Terms of the Finders’ Fees Previously Announced</description>
		<author></author>
		<category></category>
		</item>
		 		<item>
		<title>Immunovaccine Joins with Weill Cornell Medical College To Advance Anti-Cocaine Vaccine</title>
		<link>http://www.imvaccine.com/releases.php?releases_id=268</link>
		<date>Fri, 18 May 2012 00:00:00 PDT</date>
		<description>Immunovaccine Joins with Weill Cornell Medical College To Advance Anti-Cocaine Vaccine</description>
		<author></author>
		<category></category>
		</item>
		 		<item>
		<title>Immunovaccine Grants Stock Options</title>
		<link>http://www.imvaccine.com/releases.php?releases_id=267</link>
		<date>Fri, 18 May 2012 00:00:00 PDT</date>
		<description>Immunovaccine Grants Stock Options</description>
		<author></author>
		<category></category>
		</item>
		 		<item>
		<title>Immunovaccine Raises CAN$2.8M in Non-Brokered Private Placement</title>
		<link>http://www.imvaccine.com/releases.php?releases_id=266</link>
		<date>Fri, 18 May 2012 00:00:00 PDT</date>
		<description>Immunovaccine Raises CAN$2.8M in Non-Brokered Private Placement</description>
		<author></author>
		<category></category>
		</item>
		 		<item>
		<title>Webcast Presentation at the BIO CEO &amp; Investor Conference</title>
		<link>http://www.imvaccine.com/releases.php?releases_id=265</link>
		<date>Fri, 18 May 2012 00:00:00 PDT</date>
		<description>Webcast Presentation at the BIO CEO &amp; Investor Conference</description>
		<author></author>
		<category></category>
		</item>
		 </channel>
</rss>


